SCHEMBL28841007

SCHEMBL28841007

CCCCCCCCCCCCc1ccc2ccc(OC)cc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 1/20 0.53
PTGS2 P35354 2/20 0.53
CYP1A2 P05177 2/20 0.53
KDM4E B2RXH2 1/20 0.53
NPC1 O15118 1/20 0.53
LMNA P02545 1/20 0.53
TP53 P04637 1/20 0.53
CYP3A4 P08684 1/20 0.53
MAPT P10636 1/20 0.53
MAOA P21397 1/20 0.53
SLC6A2 P23975 1/20 0.53
RAB9A P51151 1/20 0.53
SLC6A3 Q01959 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
PPARG P37231 1/20 0.48
PPARA Q07869 1/20 0.48
CASP3 P42574 1/20 0.48
SENP8 Q96LD8 1/20 0.48
SENP7 Q9BQF6 1/20 0.48
SENP6 Q9GZR1 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16024669 1.00 HTR2A (0.53) HTR2APTGS2CYP1A2KDM4ENPC1
SCHEMBL16024605 1.00 HTR2A (0.53) HTR2APTGS2CYP1A2KDM4ENPC1
SCHEMBL19506648 0.97 HTR2A (0.56) HTR2APTGS2CYP1A2KDM4ENPC1
SCHEMBL16024600 0.97 HTR2A (0.56) HTR2APTGS2CYP1A2KDM4ENPC1
SCHEMBL14783441 0.97 HTR2A (0.56) HTR2APTGS2CYP1A2KDM4ENPC1
SCHEMBL7061128 0.95 PTGS2 (0.57) HTR2APTGS2CYP1A2KDM4ENPC1
SCHEMBL28131897 0.93 CYP1A2 (0.55) HTR2APTGS2CYP1A2KDM4ENPC1
SCHEMBL11246667 0.90 CYP1A2 (0.58) HTR2APTGS2CYP1A2KDM4ENPC1
SCHEMBL18556121 0.86 PTGS2 (0.55) HTR2APTGS2KDM4ELMNATP53
SCHEMBL27519533 0.86 PTGS2 (0.55) HTR2APTGS2KDM4ELMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104650110-B Novel heterocyclic compound, method for producing intermediate therefor, and use thereof 日本化药株式会社 2017-04-12 CN disclosed